Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2276–2285. doi: 10.1172/JCI119765

Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation.

A D Schecter 1, P L Giesen 1, O Taby 1, C L Rosenfield 1, M Rossikhina 1, B S Fyfe 1, D S Kohtz 1, J T Fallon 1, Y Nemerson 1, M B Taubman 1
PMCID: PMC508423  PMID: 9410905

Abstract

Tissue factor (TF) is a transmembrane glycoprotein that initiates the coagulation cascade. Because of the potential role of TF in mediating arterial thrombosis, we have examined its expression in human aortic and coronary artery smooth muscle cells (SMC). TF mRNA and protein were induced in SMC by a variety of growth agonists. Exposure to PDGF AA or BB for 30 min provided all of the necessary signals for induction of TF mRNA and protein. This result was consistent with nuclear runoff analyses, demonstrating that PDGF-induced TF transcription occurred within 30 min. A newly developed assay involving binding of digoxigenin-labeled FVIIa (DigVIIa) and digoxigenin-labeled Factor X (DigX) was used to localize cellular TF. By light and confocal microscopy, prominent TF staining was seen in the perinuclear cytoplasm beginning 2 h after agonist treatment and persisting for 10-12 h. Surface TF activity, measured on SMC monolayers under flow conditions, increased transiently, peaking 4-6 h after agonist stimulation and returning to baseline within 16 h. Peak surface TF activity was only approximately 20% of total TF activity measured in cell lysates. Surface TF-blocking experiments demonstrated that the remaining TF was found as encrypted surface TF, and also in an intracellular pool. The relatively short-lived surface expression of TF may be critical for limiting the thrombotic potential of intact SMC exposed to growth factor stimulation. In contrast, the encrypted surface and intracellular pools may provide a rich source of TF under conditions associated with SMC damage, such as during atherosclerotic plaque rupture or balloon arterial injury.

Full Text

The Full Text of this article is available as a PDF (441.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annex B. H., Denning S. M., Channon K. M., Sketch M. H., Jr, Stack R. S., Morrissey J. H., Peters K. G. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995 Feb 1;91(3):619–622. doi: 10.1161/01.cir.91.3.619. [DOI] [PubMed] [Google Scholar]
  2. Bach R. R., Moldow C. F. Mechanism of tissue factor activation on HL-60 cells. Blood. 1997 May 1;89(9):3270–3276. [PubMed] [Google Scholar]
  3. Bach R., Gentry R., Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry. 1986 Jul 15;25(14):4007–4020. doi: 10.1021/bi00362a005. [DOI] [PubMed] [Google Scholar]
  4. Brand K., Fowler B. J., Edgington T. S., Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991 Sep;11(9):4732–4738. doi: 10.1128/mcb.11.9.4732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carson S. D. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane. Blood Coagul Fibrinolysis. 1996 Apr;7(3):303–313. doi: 10.1097/00001721-199604000-00004. [DOI] [PubMed] [Google Scholar]
  6. Crossman D. C., Carr D. P., Tuddenham E. G., Pearson J. D., McVey J. H. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem. 1990 Jun 15;265(17):9782–9787. [PubMed] [Google Scholar]
  7. Donovan-Peluso M., George L. D., Hassett A. C. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells. Protein-DNA interactions with the promoter. J Biol Chem. 1994 Jan 14;269(2):1361–1369. [PubMed] [Google Scholar]
  8. Drake T. A., Ruf W., Morrissey J. H., Edgington T. S. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol. 1989 Jul;109(1):389–395. doi: 10.1083/jcb.109.1.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edgington T. S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991 Jul 12;66(1):67–79. [PubMed] [Google Scholar]
  10. Ferns G. A., Raines E. W., Sprugel K. H., Motani A. S., Reidy M. A., Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991 Sep 6;253(5024):1129–1132. doi: 10.1126/science.1653454. [DOI] [PubMed] [Google Scholar]
  11. Fernández-Ortiz A., Badimon J. J., Falk E., Fuster V., Meyer B., Mailhac A., Weng D., Shah P. K., Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994 Jun;23(7):1562–1569. doi: 10.1016/0735-1097(94)90657-2. [DOI] [PubMed] [Google Scholar]
  12. Grabowski E. F., Zuckerman D. B., Nemerson Y. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions. Blood. 1993 Jun 15;81(12):3265–3270. [PubMed] [Google Scholar]
  13. Greeno E. W., Bach R. R., Moldow C. F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 1996 Aug;75(2):281–289. [PubMed] [Google Scholar]
  14. Jiang B., Yamamura S., Nelson P. R., Mureebe L., Kent K. C. Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery. 1996 Aug;120(2):427–432. doi: 10.1016/s0039-6060(96)80319-9. [DOI] [PubMed] [Google Scholar]
  15. Kirchhofer D., Sakariassen K. S., Clozel M., Tschopp T. B., Hadváry P., Nemerson Y., Baumgartner H. R. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood. 1993 Apr 15;81(8):2050–2058. [PubMed] [Google Scholar]
  16. Kocher O., Gabbiani F., Gabbiani G., Reidy M. A., Cokay M. S., Peters H., Hüttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest. 1991 Oct;65(4):459–470. [PubMed] [Google Scholar]
  17. Koyama N., Hart C. E., Clowes A. W. Different functions of the platelet-derived growth factor-alpha and -beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res. 1994 Oct;75(4):682–691. doi: 10.1161/01.res.75.4.682. [DOI] [PubMed] [Google Scholar]
  18. Kraiss L. W., Raines E. W., Wilcox J. N., Seifert R. A., Barrett T. B., Kirkman T. R., Hart C. E., Bowen-Pope D. F., Ross R., Clowes A. W. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest. 1993 Jul;92(1):338–348. doi: 10.1172/JCI116572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Le D. T., Rapaport S. I., Rao L. V. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J Biol Chem. 1992 Aug 5;267(22):15447–15454. [PubMed] [Google Scholar]
  20. Marmur J. D., Rossikhina M., Guha A., Fyfe B., Friedrich V., Mendlowitz M., Nemerson Y., Taubman M. B. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest. 1993 May;91(5):2253–2259. doi: 10.1172/JCI116452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marmur J. D., Thiruvikraman S. V., Fyfe B. S., Guha A., Sharma S. K., Ambrose J. A., Fallon J. T., Nemerson Y., Taubman M. B. Identification of active tissue factor in human coronary atheroma. Circulation. 1996 Sep 15;94(6):1226–1232. doi: 10.1161/01.cir.94.6.1226. [DOI] [PubMed] [Google Scholar]
  22. Maynard J. R., Heckman C. A., Pitlick F. A., Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest. 1975 Apr;55(4):814–824. doi: 10.1172/JCI107992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miletich J. P., Broze G. J., Jr, Majerus P. W. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X. Anal Biochem. 1980 Jul 1;105(2):304–310. doi: 10.1016/0003-2697(80)90462-5. [DOI] [PubMed] [Google Scholar]
  24. Moreno P. R., Bernardi V. H., López-Cuéllar J., Murcia A. M., Palacios I. F., Gold H. K., Mehran R., Sharma S. K., Nemerson Y., Fuster V. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996 Dec 15;94(12):3090–3097. doi: 10.1161/01.cir.94.12.3090. [DOI] [PubMed] [Google Scholar]
  25. Mulder A. B., Smit J. W., Bom V. J., Blom N. R., Ruiters M. H., Halie M. R., van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood. 1996 Aug 15;88(4):1306–1313. [PubMed] [Google Scholar]
  26. Nemerson Y. Tissue factor and hemostasis. Blood. 1988 Jan;71(1):1–8. [PubMed] [Google Scholar]
  27. Patton W. F., Erdjument-Bromage H., Marks A. R., Tempst P., Taubman M. B. Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing. J Biol Chem. 1995 Sep 8;270(36):21404–21410. doi: 10.1074/jbc.270.36.21404. [DOI] [PubMed] [Google Scholar]
  28. Pawashe A. B., Golino P., Ambrosio G., Migliaccio F., Ragni M., Pascucci I., Chiariello M., Bach R., Garen A., Konigsberg W. K. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994 Jan;74(1):56–63. doi: 10.1161/01.res.74.1.56. [DOI] [PubMed] [Google Scholar]
  29. Rapaport S. I., Rao L. V. The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost. 1995 Jul;74(1):7–17. [PubMed] [Google Scholar]
  30. Sevinsky J. R., Rao L. V., Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996 Apr;133(2):293–304. doi: 10.1083/jcb.133.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Speidel C. M., Eisenberg P. R., Ruf W., Edgington T. S., Abendschein D. R. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation. 1995 Dec 1;92(11):3323–3330. doi: 10.1161/01.cir.92.11.3323. [DOI] [PubMed] [Google Scholar]
  32. Spicer E. K., Horton R., Bloem L., Bach R., Williams K. R., Guha A., Kraus J., Lin T. C., Nemerson Y., Konigsberg W. H. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5148–5152. doi: 10.1073/pnas.84.15.5148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Taubman M. B., Marmur J. D., Rosenfield C. L., Guha A., Nichtberger S., Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest. 1993 Feb;91(2):547–552. doi: 10.1172/JCI116234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Taubman M. B., Rollins B. J., Poon M., Marmur J., Green R. S., Berk B. C., Nadal-Ginard B. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res. 1992 Feb;70(2):314–325. doi: 10.1161/01.res.70.2.314. [DOI] [PubMed] [Google Scholar]
  35. Thiruvikraman S. V., Guha A., Roboz J., Taubman M. B., Nemerson Y., Fallon J. T. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest. 1996 Oct;75(4):451–461. [PubMed] [Google Scholar]
  36. Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2839–2843. doi: 10.1073/pnas.86.8.2839. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES